Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Novartis”
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
Taiwan
- A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.Not Yet Recruiting
Sponsor: Novartis Pharmaceuticals
Primary Immune Thrombocytopenia (ITP)
- A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate CancerActive Not Recruiting
Sponsor: Memorial Sloan Kettering Cancer Center
Prostate Cancer
United States
Sponsor: Novartis Pharmaceuticals
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Italy
Sponsor: Novartis Pharmaceuticals
B-cell Acute Lymphoblastic Leukemia · Diffuse Large B-cell Lymphoma
Canada, Japan
- Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast CancerActive Not Recruiting
Sponsor: City of Hope Medical Center
Breast Neoplasms · HER2/Neu Positive · Geriatric Health Services
United States
Sponsor: SOLTI Breast Cancer Research Group
Metastatic Breast Cancer
United States, Portugal, Spain
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Keratoconjunctivitis Sicca
United States
Sponsor: Novartis Pharmaceuticals
Primary Hypercholesterolemia · Mixed Dyslipidemia
India
Sponsor: Novartis Pharmaceuticals
Aortic Stenosis
United States, Austria, Belgium, Canada, Czechia +10 more
- Roll-over Study to Allow Continued Access to RibociclibActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Metastatic Breast Cancer
United States, Argentina, Brazil, China, Costa Rica +17 more
Sponsor: Novartis Pharmaceuticals
Hidradenitis Suppurativa
Canada
- Phase 2 Study of Rapcabtagene Autoleucel in MyositisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Idiopathic Inflammatory Myopathies
United States, Australia, Brazil, France, Germany +10 more
Sponsor: Novartis Pharmaceuticals
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
United States, Singapore
- Post-authorization Safety Study of Iptacopan in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Using Data From the IPIG PNH RegistryActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Hemoglobinuria, Paroxysmal
Switzerland
Sponsor: Novartis Pharmaceuticals
Achilles Tendinopathy
United States, France, Germany
Sponsor: Novartis Pharmaceuticals
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
United States, Australia, Brazil, Canada, China +9 more
Sponsor: Novartis Pharmaceuticals
Advanced HR+/HER2- Breast Cancer · Advanced CCNE1-amplified Solid Tumors · Metastatic Castration-resistant Prostate Cancer (mCRPC)
- HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue SarcomasActive Not Recruiting
Sponsor: Centre Leon Berard
Advanced Soft-tissue Sarcoma · Metastatic Soft-tissue Sarcoma
France
- A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid TumorsActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Mesothelioma
United States, Australia, Canada, France, Germany +6 more
Sponsor: Novartis Pharmaceuticals
Polymyalgia Rheumatica
United States, Argentina, Australia, Belgium, Brazil +21 more
Sponsor: M.D. Anderson Cancer Center
Breast Cancer
United States
Sponsor: M.D. Anderson Cancer Center
Leukemia · Mantle Cell Lymphoma · Myelofibrosis
United States
- E3 Diabetes - Closing the Gap in Diabetes ControlActive Not Recruiting
Sponsor: Rush University Medical Center
Type 2 Diabetes
United States
Sponsor: Novartis Pharmaceuticals
Atherosclerotic Cardiovascular Disease, ASCVD